Unique ID issued by UMIN | UMIN000039901 |
---|---|
Receipt number | R000045507 |
Scientific Title | Long term flaxseed consumption for cognitive function in the elderly |
Date of disclosure of the study information | 2020/03/24 |
Last modified on | 2022/03/25 15:55:37 |
Long term flaxseed consumption for cognitive function in the elderly
Long term flaxseed consumption for cognitive function in the elderly
Long term flaxseed consumption for cognitive function in the elderly
Long term flaxseed consumption for cognitive function in the elderly
Japan |
Healthy adults
Adult |
Others
NO
To investigate the effect of oral intake of flaxseed oil which is rich in alpha-linolenic acid, and classified as the omega-3 fatty acids on cognitive function of healthy subjects.
Efficacy
Exploratory
Others
Not applicable
Before and after 6 and 12 weeks of Flaxseed oil consumption cognitive function will be evaluated.
Before and after 6 and 12 weeks of flaxseed oil consumption, the following items will be evaluated:
Food frequency
Depression
QOL
Physical conditions
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Participants in flaxseed oil group are asked to take a flaxseed oil containing package with no prints.
Flaxseed oil 3.7g/package, 1package/day for 12 weeks.
Corn oil is used as placebo. Corn oil containing package with no prints is used.
corn oil 3.7g/package,1package/day for 12 weeks.
65 | years-old | <= |
80 | years-old | >= |
Male and Female
1.Mini Mental State Examination (MMSE) more than 27points
2.Clinical Dementia Rating (CDR) 0point
3.65-80 years old when admitted
4.Right handed
5.Signed informed consent
1.Severe past history of brain, psychological and internal disease
2.Severe visual and hearing disturbance
3.Excessive slimming/obesity (BMI less than 17, more than 30)
4.History of long term flaxseed oil consumption
5.Frequent fish intake
6.Mental illness or psychiatric symptoms and are judged to be difficult to participate in the study by physician
7.Any participant who is judged not suitable for this study by physician
60
1st name | Ryuta |
Middle name | |
Last name | Kawashima |
Tohoku University
Institute of Development, Aging and Cancer
9808575
4-1 Seiryocho, Aobaku, Sendai, Miyagi
022-717-7988
ryuta.kawashima.a6@tohoku.ac.jp
1st name | Toshimi |
Middle name | |
Last name | Ogawa |
Tohoku University
Institute of Development, Aging and Cancer
9808575
4-1 Seiryocho, Aobaku, Sendai, Miyagi
022-717-7988
toshimi.ogawa.e6@tohoku.ac.jp
Tohoku University
NIPPON FLOUR MILLS Co.,Ltd
Other
Ethics Committee Tohoku University Graduate School of Medicine
2-1 Seiryocho, Aobaku, Sendai, Miyagi
022-717-8007
med-kenkyo@grp.tohoku.ac.jp
NO
2020 | Year | 03 | Month | 24 | Day |
Unpublished
60
Completed
2020 | Year | 03 | Month | 23 | Day |
2020 | Year | 04 | Month | 30 | Day |
2020 | Year | 09 | Month | 01 | Day |
2021 | Year | 10 | Month | 01 | Day |
2020 | Year | 03 | Month | 22 | Day |
2022 | Year | 03 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045507